These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1738172)

  • 1. Inhibition of breast cancer growth by suramin.
    Vignon F; Prebois C; Rochefort H
    J Natl Cancer Inst; 1992 Jan; 84(1):38-42. PubMed ID: 1738172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
    Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
    Huber M; Poulin R
    J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
    Gansler T; Vaghmar N; Olson JJ; Graham SD
    J Urol; 1992 Sep; 148(3):910-4. PubMed ID: 1512858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Dorssers LC; Berns EM; Klijn JG
    Int J Cancer; 1992 May; 51(3):439-44. PubMed ID: 1592534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.
    Panagiotou S; Hatzoglou A; Calvo F; Martin PM; Castanas E
    J Cell Biochem; 1998 Dec; 71(3):416-28. PubMed ID: 9831078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
    Pollak M; Richard M
    J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
    Confort C; Rochefort H; Vignon F
    Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
    Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
    J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.